Cancer FDA approves first drug to treat rare adrenal cancer Azedra has received FDA approval to become the first and only treatment for a type of rare adrenal cancer.
News Can Purdue finally get its bankruptcy plan over the line? OxyContin manufacturer Purdue is on the brink of a bankruptcy deal that could put years of opioid liability litigation in its rearview mirror.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.